In many clinical trials, patients are not followed continuously. This means their vital status may not be immediately recorded. In such cases, the results from the Kaplan-Meier estimator or the log rank test, popular methods used for survival analysis, may be biased or inconsistent. Hu and Tsiatis first produced a new estimator to estimate survival distribution for right-censored data with delayed ascertainment, Van der Laan and Hubbard modified their estimator. We investigate each of these proposed estimators and their properties. Using simulations, we compare these new estimators to each other and to the Kaplan-Meier estimator using different sample sizes, different failure rates, and different maximum delay times. The public health impor...
In longitudinal cohort studies, potential risk factors are measured at baseline, subjects are follow...
Causal effects in right-censored survival data can be formally defined as the difference in the marg...
The restricted mean survival time (RMST) is a clinically meaningful summary measure in studies with ...
In many clinical trials, patients are not followed continuously. This means their vital status may n...
Right censored data is the type of data in which the interested event has not been observed in worki...
In clinical trials, information about certain time points may be of interest in making decisions abo...
One of the primary problems facing statisticians who work with survival data is the loss of in-forma...
For many sources of survival data, there is a delay between the recording of vital status and its av...
In many medical studies, the outcome of interest may be the time from a starting point to a predefin...
Analyzing events over time is often complicated by incomplete, or censored, observations. Special no...
Clinical trials with survival endpoints are typically designed to enroll patients for a specified nu...
In this thesis two approaches of inferences on median failure times are considered and developed to ...
In the past decade applications of the statistical methods for survival data analysis have been exte...
In survival analysis, it is very common to have censored data in which the occurrence times of the e...
One of the primary problems facing statisticians who work with survival data is the loss of informat...
In longitudinal cohort studies, potential risk factors are measured at baseline, subjects are follow...
Causal effects in right-censored survival data can be formally defined as the difference in the marg...
The restricted mean survival time (RMST) is a clinically meaningful summary measure in studies with ...
In many clinical trials, patients are not followed continuously. This means their vital status may n...
Right censored data is the type of data in which the interested event has not been observed in worki...
In clinical trials, information about certain time points may be of interest in making decisions abo...
One of the primary problems facing statisticians who work with survival data is the loss of in-forma...
For many sources of survival data, there is a delay between the recording of vital status and its av...
In many medical studies, the outcome of interest may be the time from a starting point to a predefin...
Analyzing events over time is often complicated by incomplete, or censored, observations. Special no...
Clinical trials with survival endpoints are typically designed to enroll patients for a specified nu...
In this thesis two approaches of inferences on median failure times are considered and developed to ...
In the past decade applications of the statistical methods for survival data analysis have been exte...
In survival analysis, it is very common to have censored data in which the occurrence times of the e...
One of the primary problems facing statisticians who work with survival data is the loss of informat...
In longitudinal cohort studies, potential risk factors are measured at baseline, subjects are follow...
Causal effects in right-censored survival data can be formally defined as the difference in the marg...
The restricted mean survival time (RMST) is a clinically meaningful summary measure in studies with ...